Talphera (TLPH)

• Market cap: $55M
• 1 day: -0.84%
• 5 days: -9.23%
• 1 month: -10.61%
• 3 months: 20.41%
• 6 months: 145.32%
• Year to date: 99.97%
• 1 year: 74.81%
• 5 years: -95.43%
• 10 years: -98.49%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13